{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "regularMarketChangePercent": -0.76589227, "regularMarketPrice": 194.35, "exchange": "FRA", "shortName": "UTD THERAP. (DEL.) DL-,01", "longName": "United Therapeutics Corporation", "messageBoardId": "finmb_36018", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "marketState": "REGULAR", "esgPopulated": false, "priceEpsCurrentYear": 16.37321, "sharesOutstanding": 46854500, "bookValue": 109.708, "fiftyDayAverage": 208.595, "fiftyDayAverageChange": -14.244995, "fiftyDayAverageChangePercent": -0.068290204, "twoHundredDayAverage": 228.48325, "twoHundredDayAverageChange": -34.13324, "twoHundredDayAverageChangePercent": -0.14939056, "marketCap": 9320288256, "forwardPE": 12.034057, "priceToBook": 1.7715209, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "1.7 - Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 946882800000, "priceHint": 2, "regularMarketChange": -1.5, "regularMarketTime": 1683871252, "regularMarketDayHigh": 194.35, "regularMarketDayRange": "194.35 - 194.35", "regularMarketDayLow": 194.35, "regularMarketVolume": 50, "regularMarketPreviousClose": 195.85, "bid": 196.05, "ask": 196.45, "bidSize": 300, "askSize": 300, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 194.35, "averageDailyVolume3Month": 9, "averageDailyVolume10Day": 12, "fiftyTwoWeekLowChange": 19.200012, "fiftyTwoWeekLowChangePercent": 0.1096204, "fiftyTwoWeekRange": "175.15 - 271.4", "fiftyTwoWeekHighChange": -77.04999, "fiftyTwoWeekHighChangePercent": -0.28389826, "fiftyTwoWeekLow": 175.15, "fiftyTwoWeekHigh": 271.4, "earningsTimestamp": 1683118800, "earningsTimestampStart": 1690893000, "earningsTimestampEnd": 1691411400, "trailingAnnualDividendRate": 0.0, "trailingPE": 14.813263, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": 13.12, "epsForward": 16.15, "epsCurrentYear": 11.87, "symbol": "UTH.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "1040 Spring Street", "city": "Silver Spring", "state": "MD", "zip": "20910", "country": "United States", "phone": "301 608 9292", "fax": "301 608 9291", "website": "https://www.unither.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertension (PAH) to diminish symptoms associated with exercise; Tyvaso, an inhaled solution via ultrasonic nebulizer; Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Remunity Pump, a small, lightweight, durable pump and separate controller; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; Unituxin, a monoclonal antibody for treating high-risk neuroblastoma; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. The company also engages in developing RemoPro and Ralinepag for the treatment of PAH; Aurora-GT, a gene therapy product to rebuild the blood vessels in the lungs; and TETON studies, which are the studies of Tyvaso for the treatment of idiopathic pulmonary fibrosis. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was incorporated in 1996 and is headquartered in Silver Spring, Maryland.", "fullTimeEmployees": 985, "companyOfficers": [{"maxAge": 1, "name": "Dr. Martine A. Rothblatt J.D., M.B.A., Ph.D.", "age": 67, "title": "Founder, Chairman & CEO", "yearBorn": 1955, "fiscalYear": 2022, "totalPay": {"raw": 5322204, "fmt": "5.32M", "longFmt": "5,322,204"}, "exercisedValue": {"raw": 56145352, "fmt": "56.15M", "longFmt": "56,145,352"}, "unexercisedValue": {"raw": 497331264, "fmt": "497.33M", "longFmt": "497,331,264"}}, {"maxAge": 1, "name": "Mr. Michael I. Benkowitz", "age": 50, "title": "Pres & COO", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": {"raw": 2828435, "fmt": "2.83M", "longFmt": "2,828,435"}, "exercisedValue": {"raw": 7832730, "fmt": "7.83M", "longFmt": "7,832,730"}, "unexercisedValue": {"raw": 90841432, "fmt": "90.84M", "longFmt": "90,841,432"}}, {"maxAge": 1, "name": "Mr. James C. Edgemond", "age": 54, "title": "CFO & Treasurer", "yearBorn": 1968, "fiscalYear": 2022, "totalPay": {"raw": 2005784, "fmt": "2.01M", "longFmt": "2,005,784"}, "exercisedValue": {"raw": 1487706, "fmt": "1.49M", "longFmt": "1,487,706"}, "unexercisedValue": {"raw": 71325464, "fmt": "71.33M", "longFmt": "71,325,464"}}, {"maxAge": 1, "name": "Mr. Paul A. Mahon J.D.", "age": 58, "title": "Exec. VP, Gen. Counsel & Corp. Sec.", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": {"raw": 2309202, "fmt": "2.31M", "longFmt": "2,309,202"}, "exercisedValue": {"raw": 13200417, "fmt": "13.2M", "longFmt": "13,200,417"}, "unexercisedValue": {"raw": 70995872, "fmt": "71M", "longFmt": "70,995,872"}}, {"maxAge": 1, "name": "Mr. Dewey  Steadman C.F.A.", "title": "Head of Investor Relations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Holly  Hobson", "title": "Associate VP of HR", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Kevin T. Gray", "title": "Sr. VP of Strategic Operations & Logistics", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Patrick  Poisson", "age": 54, "title": "Exec. VP of Technical Operations", "yearBorn": 1968, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Gil  Golden", "title": "Sr. VP & Chief Medical Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 4, "boardRisk": 5, "compensationRisk": 5, "shareHolderRightsRisk": 3, "overallRisk": 4, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}